Technology

ADMA Biologics

$2.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.18 (+8.74%) Today
+$0.02 (+0.89%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ADMA Biologics and other stocks, options, and ETFs commission-free!

About ADMA

ADMA Biologics Inc Common Stock, also called ADMA Biologics, is engaged in the manufacturing, marketing and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment comprises of the immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ. The listed name for ADMA is ADMA Biologics Inc Common Stock.

CEO
Adam S. Grossman
Employees
314
Headquarters
Ramsey, New Jersey
Founded
2006
Market Cap
211.79M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.21M
High Today
$2.38
Low Today
$2.10
Open Price
$2.17
Volume
14.11M
52 Week High
$4.65
52 Week Low
$1.45

Collections

ADMA Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

VCR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure